HIV treatment
Policy brief
July 2017
WHO/HIV/2017.18
3rd Edition – July 2017
www.msfaccess.org
This summary brief highlights key messages from the updated World Health Organization’s recommendation on tranexamic acid (TXA) for the treatment of postpartum haemorrhage (PPH), including policy and program implications for translating the TXA recommendation into action at the country level. In 2...012, WHO published recommendations for the prevention and treatment of postpartum haemorrhage, including a recommendation on the use of TXA for treatment of PPH. The 2017 updated WHO Recommendation on TXA is based on new evidence on use of TXA for treatment of PPH. This summary brief is intended for policy-makers, programme managers, educators and providers.
more
Botswana CPD.
The 6th Government of Botswana/UNFPA Country Programme (2017-2021) is focusing on a transformative development agenda that is universal, inclusive, human rights-based, integrated and anchored in the principle of equality and leaving no one behind, while reaching the furthest left beh...ind first. The country programme will contribute directly to the three outcomes of the United Nations Sustainable Development Framework (2017-2021).
more
PLOS ONE | https://doi.org/10.1371/journal.pone.0185526 September 28, 2017
Global Health and Tropical Medicine, GHTM, Instituto de Higiene e Medicina Tropical, IHMT, Universidade Nova de Lisboa, UNL, Lisboa, Portugal
- Pacific Possible Background Paper No.6
Protecting the fundamental rights of people affected by HIV
Under the Constitution of the Republic of the Union of Myanmar (2008), every citizen - including people living with HIV - has the right to work, access health care, and receive basic education.
However, stigma and discrimination r...emains, preventing people living with HIV (PLHIV) from accessing health services, maintaining employment and receiving education – denying them of the fundamental rights that all Myanmar citizens are entitled to under the law.
No publication year indicated.
more
ecancer 11 755 / DOI: 10.3332/ecancer.2017.755